Concourse Financial Group Securities, Inc. Adaptimmune Therapeutics PLC Transaction History

Concourse Financial Group Securities, Inc.

$1.64 Billion
Q3 2024

Number of Shares

Previous 0 NaN%

Holding current value

Previous $0 NaN%

% of portfolio

0.0%

Previous 0.0%

26 transactions

Quarter	Operation	Price Per share
Q3 2024 Oct 10, 2024	BUY	$0.92 - $1.39 $0 - $0
Q2 2024 Jul 23, 2024	BUY	$0.83 - $1.47 $0 - $0
Q1 2024 Apr 30, 2024	BUY	$0.7 - $1.75 $0 - $0
Q4 2023 Feb 07, 2024	BUY	$0.43 - $0.79 $0 - $0
Q3 2023 Oct 30, 2023	BUY	$0.73 - $1.04 $0 - $0
Q3 2023 Oct 25, 2023	BUY	$0.73 - $1.04 $0 - $0
Q2 2023 Aug 10, 2023	BUY	$0.9 - $1.51 $0 - $0
Q1 2023 May 15, 2023	BUY	$1.06 - $2.16 $0 - $0
Q4 2022 Jan 30, 2023	BUY	$1.05 - $2.53 $0 - $0
Q3 2022 Nov 15, 2022	BUY	$1.06 - $2.41 $0 - $0
Q2 2022 Aug 09, 2022	BUY	$1.33 - $2.28 $0 - $0
Q1 2022 May 09, 2022	BUY	$1.73 - $4.06 $0 - $0
Q4 2021 Feb 07, 2022	BUY	$3.5 - $5.68 $0 - $0
Q3 2021 Nov 09, 2021	BUY	$3.44 - $6.37 $0 - $0
Q2 2021 Aug 13, 2021	BUY	$3.86 - $5.78 $0 - $0
Q1 2021 May 13, 2021	BUY	$4.9 - $6.83 $0 - $0
Q4 2020 Feb 02, 2021	BUY	$4.0 - $9.2 $0 - $0
Q3 2020 Nov 13, 2020	BUY	$7.66 - $10.78 $0 - $0
Q2 2020 Aug 13, 2020	BUY	$2.58 - $12.1 $0 - $0
Q1 2020 May 13, 2020	BUY	$1.2 - $4.52 $0 - $0
Q4 2019 Feb 14, 2020	BUY	$0.72 - $1.43 $0 - $0
Q3 2019 Nov 13, 2019	BUY	$1.43 - $3.81 $0 - $0
Q2 2019 Aug 13, 2019	BUY	$3.23 - $5.41 $0 - $0
Q1 2019 May 15, 2019	BUY	$3.63 - $6.06 $0 - $0
Q4 2018 Feb 14, 2019	BUY	$3.76 - $14.16 $0 - $0
Q3 2018 Nov 13, 2018	BUY	$8.27 - $13.56 $0 - $0

Others Institutions Holding ADAP

# of Institutions

Shares Held

150M

Call Options Held

60.8K

Put Options Held

5.8K

Matrix Capital Management Company, LP Waltham, MA

37.7M
Shares

$24.9 Million
1.71% of portfolio
Eco R1 Capital, LLC San Francisco, CA

27.4M
Shares

$18.1 Million
1.13% of portfolio
Nea Management Company, LLC Timonium, MD

17.1M
Shares

$11.3 Million
1.24% of portfolio
Baillie Gifford & CO

16.8M
Shares

$11.1 Million
0.01% of portfolio
Long Focus Capital Management, LLC San Juan, PR

13.3M
Shares

$8.78 Million
0.46% of portfolio

View Full List

About Adaptimmune Therapeutics PLC

Ticker ADAP
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 163,370,000
Market Cap $108M
Description
Adaptimmune Therapeutics plc, a clinical-stage biopharmaceutical company, focuses on providing novel cell therapies primarily to patients with solid tumors in the United States and the United Kingdom. The company's specific peptide enhanced affinity receptor (SPEAR) T-cell platform enables it to identify cancer targets. It is developing ADP-A2M4...

More about ADAP

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Concourse Financial Group Securities, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Concourse Financial Group Securities, Inc. with notifications on news.

Account